West of Scotland Formulary
NHS Scotland

2.5.1 Vasodilator antihypertensive drugs

Ambrisentan
Ambrisentan 10mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Ambrisentan 5mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Bosentan
Bosentan 125mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Bosentan 62.5mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Hydralazine
Hydralazine 20mg powder for solution for injection ampoules

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Hypertension
Hydralazine 25mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Heart failure
Hydralazine 50mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Heart failure
Iloprost
Iloprost 10micrograms/1ml nebuliser liquid ampoules

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Iloprost 20micrograms/1ml nebuliser liquid ampoules

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Macitentan
Macitentan 10mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Riociguat
Riociguat 1.5mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Riociguat 1mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Riociguat 2.5mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Riociguat 2mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag
Selexipag 1.2mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag 1.4mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag 1.6mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag 1mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag 200microgram tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag 400microgram tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag 600microgram tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Selexipag 800microgram tablets

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Sotatercept
Winrevair 45mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension
Winrevair 60mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Pulmonary arterial hypertension